Abstract: PO2300
Provider Practice Evaluation Survey: Assessment of Primary Care Provider Perspectives on Care Delivery for CKD Patients in Alberta
Session Information
- CKD: Drugs, Diet, and Other Determinants
November 04, 2021 | Location: On-Demand, Virtual Only
Abstract Time: 10:00 AM - 12:00 PM
Category: CKD (Non-Dialysis)
- 2101 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention
Authors
- Bello, Aminu K., University of Alberta, Edmonton, Alberta, Canada
- Zaidi, Deenaz, University of Alberta, Edmonton, Alberta, Canada
- Ye, Feng, University of Alberta, Edmonton, Alberta, Canada
- Okpechi, Ikechi G., University of Alberta, Edmonton, Alberta, Canada
Background
Chronic kidney disease (CKD) is highly prevalent in the adult population of Canada, with a steady rise in end-stage renal disease. The objective of this study was to assess current modes of practice regarding CKD patients, and assess barrier and facilitators in primary care for managing and referring CKD patients using electronic consultation (eReferral).
Methods
The Provider Practice Evaluation Survey was launched for primary care providers [PCPs (family physicians or general practitioners)] licensed to practice in Alberta. Associations between barriers and facilitators to electronic consultations and clinic practice parameters; and associations between screening for CKD in patients and clinic practice parameters were analyzed. Modified Poisson regression with robust error variance was used to estimate the relative risk (RR) and 95% confidence interval.
Results
A total of 48 PCPs responded to the survey. Awareness about the availability of the eReferral tool was more likely to be a barrier to use eReferral for PCPs of South Zone as compared to PCPs from Edmonton (RR: 2.00, 95% CI: 1.07-3.74). Compared to PCPs with >5% CKD patients in their clinical practice, PCPs with 16% to 26% CKD patients were more likely to perceive barriers to use eReferral; including the ease of use for the eReferral tool (RR: 1.62, 95% CI: 1.05-2.51), and limited staff and technical support as a barrier for eReferral (RR: 2.00, 95%CI: 1.18-3.40). There was a negative association between PCPs aged between 40 and 60 years and time constraints as a barrier compared with those younger than 40 years (RR: 0.66, 95% CI: 0.46-0.95). Regarding screening tools (criteria) to diagnose CKD, PCPs who had not used the eReferral tools were less likely to use hypertension (RR: 0.86, 95% CI: 0.75-0.98), diabetes (RR: 0.89, 95% CI: 0.79-0.999), and cardiovascular disease (RR: 0.72, 95% CI: 0.59-0.89) as CKD diagnostic tools compared to those using eReferral nephrology advice request tool.
Conclusion
The results will help implement innovative steps to rectify barriers to adoption of the eReferral system and standardized CKD diagnostic guidelines to improve patient care in Canada.